Compare ABAT & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABAT | KMDA |
|---|---|---|
| Founded | 2011 | 1990 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.6M | 458.6M |
| IPO Year | 2013 | 2013 |
| Metric | ABAT | KMDA |
|---|---|---|
| Price | $3.32 | $8.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 2.9M | 74.8K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | ★ 43.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $145.40 | $14.04 |
| Revenue Next Year | N/A | $7.99 |
| P/E Ratio | ★ N/A | $24.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.86 | $5.54 |
| 52 Week High | $11.49 | $9.35 |
| Indicator | ABAT | KMDA |
|---|---|---|
| Relative Strength Index (RSI) | 39.04 | 49.84 |
| Support Level | $3.22 | $6.69 |
| Resistance Level | $3.88 | $8.88 |
| Average True Range (ATR) | 0.21 | 0.28 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 21.52 | 31.87 |
American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.